Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | 4 | 1 | 1 | 1 | €1.35 | €5.10 | 278.019% |
| scPharmaceuticals | 3 | 1 | 0 | 1 | €4.02 | €16.43 | 308.716% |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €29.75 | - | - |
| Formycon AG | 3 | 1 | 0 | 0 | €39.90 | €100.00 | 150.627% |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.69 | €1.20 | -28.994% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €31.40 | €50.00 | 59.236% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.84 | €5.51 | 554.941% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 1 | €1.46 | €18.30 | 1149.727% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.40 | - | - |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.98 | - | - |
| Palisade Bio Inc. | 2 | 1 | 1 | 1 | €0.34 | €11.28 | 3205.129% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 1 | €37.60 | €50.00 | 32.979% |
| Enlivex Therapeutics Ltd. | 2 | 1 | 2 | 1 | €1.34 | - | - |
| Pharma Mar S.A. | 0 | 1 | 0 | 1 | €28.74 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €3.00 | - | - |
| BeiGene Ltd ADR | 8 | 1 | 1 | 0 | €130.00 | €255.89 | 96.839% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 1 | €2.91 | €30.00 | 930.928% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.26 | - | - |
| Abeona Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.06 | €33.73 | 1002.235% |
| Medigene AG | 0 | 2 | 0 | 1 | €1.49 | €1.00 | -32.886% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 2 | €0.73 | €6.53 | 799.587% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.30 | €0.000 | -100.000% |
| Adaptimmune Therapeutics PLC ADR | 1 | 2 | 0 | 2 | €0.99 | €1.25 | 26.263% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 1 | 0 | €1.00 | €3.65 | 265.998% |